Table 1.
Clinical and biochemical characteristics of patients with nonalcoholic fatty liver disease and controls
| Controls (n=37) | Patients with NAFLD (n=41) | P | |
|---|---|---|---|
| Gender, male/female, n | 17/20 | 27/14 | NS |
| Age, years | 34.5±8.6 | 37.9±8.9 | NS |
| BMI, kg/m2 | 24.20±3.26 | 29.50±3.97 | <0.001 |
| SBP, mm Hg | 118.0±13.8 | 129.3±14.8 | 0.001 |
| DBP, mm Hg | 75.0±11.5 | 79.6±12.5 | NS |
| Heart rate, beats/min | 78.9±13.9 | 76.6±13.4 | NS |
| Pulse pressure, mm Hg | 43.0±10.6 | 49.2±12.3 | 0.020 |
| Waist circumference, cm | 89.5±9.7 | 106.0±11.9 | <0.001 |
| Smoking | 13 | 15 | NS |
| HT | 3 | 9 | NS |
| Anti-HT treatment | 3 | 7 | NS |
| Family history of CAD | 7 | 5 | NS |
| Hemoglobin, g/dL | 13.77±1.40 | 15.0±1.20 | <0.001 |
| Creatinine, mg/dL | 0.77±0.12 | 0.86±0.14 | 0.002 |
| FBG, mg/dL | 91.2±7.0 | 98.6±9.9 | <0.001 |
| LDL, mg/dL | 118.0±33.0 | 140.7±40.3 | 0.009 |
| HDL, mg/dL | 49.0±9.9 | 39.7±8.9 | <0.001 |
| Total cholesterol, mg/dL | 183.5±36.1 | 212.3±42.8 | 0.002 |
| Triglycerides, mg/dL | 87(75–101) | 158(126–198) | <0.001 |
BMI - body mass index; CAD - coronary artery disease; DBP - diastolic blood pressure; FBG - fasting blood glucose; HDL - high-density lipoprotein cholesterol; HT - hypertension; LDL - low-density lipoprotein cholesterol; NAFLD - nonalcoholic fatty liver disease; NS - nonsignificant; SBP - systolic blood pressure. Student’s t-test or the Mann–Whitney U test was used for comparison of groups. Categorical variables were compared using the Pearson chi-square test